Search Results 221-230 of 507 for ✍위너 [원탑보증.com/가입코드 111] sbc가입코드 ✍

  1. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  2. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

    About this study. This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD and elevated LDL-C despite maximum ...

  3. Publications - Abhishek A. Mangaonkar, M.B.B.S. - Mayo Clinic

    ... 111 bone marrow samples from 52 patients. Am J Clin Pathol. 2024 Jun 3; 161 (6):609-624. View PubMed; Baranwal A, Gurney M, Basmaci R, Katamesh B, He R ...

  4. ... 111 301000059,HC AMPHI WESTERN BLOT,391 301000060,HC AMYLASE ASSAY,55 301000061,HC AMYLASE PANCREATIC ASSAY,61 301000062,HC AMYLASE URINE ASSAY,60 301000063 ...

  5. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as melphalan, work in ...

  6. WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    WEE1 inhibitor AZD1775 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  7. A Study of Mavacamten in Patients with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICK-HCM or EXPLORER-HCM Trials - Mayo Clinic

    The purpose of this study is to assess the long-term safety and tolerability of mavacamten in participants with hypertrophic cardiomyopathy (HCM) previously ...

  8. Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate how children and young adults perceive their midline sternotomy scars (in terms of appearance, associated symptoms, ...